Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients

Background The aim of this study was to assess the risk factors for atrophic progression of patients with papilloedema secondary to intracranial hypertension, using optical coherence tomography parameters.Methods A retrospective study was conducted at Marseille University Hospitals’ Ophthalmology de...

Full description

Bibliographic Details
Main Authors: Bertrand Audoin, Sarah Demortiere, Penelope Tilsley, Ruben Attia, Ruben Fitoussi, Kevin Mairot, Jan-Patrick Stellman, Thierry David, Natacha Stolowy
Format: Article
Language:English
Published: BMJ Publishing Group 2023-12-01
Series:BMJ Open Ophthalmology
Online Access:https://bmjophth.bmj.com/content/8/1/e001375.full
_version_ 1797367556008312832
author Bertrand Audoin
Sarah Demortiere
Penelope Tilsley
Ruben Attia
Ruben Fitoussi
Kevin Mairot
Jan-Patrick Stellman
Thierry David
Natacha Stolowy
author_facet Bertrand Audoin
Sarah Demortiere
Penelope Tilsley
Ruben Attia
Ruben Fitoussi
Kevin Mairot
Jan-Patrick Stellman
Thierry David
Natacha Stolowy
author_sort Bertrand Audoin
collection DOAJ
description Background The aim of this study was to assess the risk factors for atrophic progression of patients with papilloedema secondary to intracranial hypertension, using optical coherence tomography parameters.Methods A retrospective study was conducted at Marseille University Hospitals’ Ophthalmology departments between December 2015 and December 2021. All patients with papilloedema resulting from elevated intracranial hypertension at the initial presentation were included. Ophthalmological evaluations included analysing retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) and total peripapillary retinal thickness (RT).Results The study included 222 eyes from 113 patients. The main aetiologies of intracranial hypertension were idiopathic intracranial hypertension (49/113), intracranial tumours (33/113) and cerebral venous thrombosis (15/113). The initial RNFL and RT showed significant correlations with optic atrophy. The mean RNFL was 199.63 µm in the ‘no atrophy’ group and 365.28 µm in the ‘atrophy’ group (p<0.001). Similarly, the mean RT was 483.72 µm in the ‘non-atrophy’ group and 796.69 µm in the ‘atrophy’ group (p<0.001). The presence of peripapillary haemorrhages showed a strong correlated with optic atrophy with an OR=19.12 (p<0.001). Impaired initial visual acuity was also associated with final optic atrophy with an OR=7.76 (p=0.020). Furthermore, impaired initial GCL was a major predictor of optic atrophy (OR=18.25 (p=0.021)).Conclusion Our study highlights the risk factors for optic atrophy in papilloedema, aiming to facilitate the early detection of patients at a high risk of vision loss and enable more aggressive medical or surgical management.
first_indexed 2024-03-08T17:20:01Z
format Article
id doaj.art-9e026cf491914bb6a9c7eb9fd7fc260c
institution Directory Open Access Journal
issn 2397-3269
language English
last_indexed 2024-03-08T17:20:01Z
publishDate 2023-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Ophthalmology
spelling doaj.art-9e026cf491914bb6a9c7eb9fd7fc260c2024-01-03T08:15:08ZengBMJ Publishing GroupBMJ Open Ophthalmology2397-32692023-12-018110.1136/bmjophth-2023-001375Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patientsBertrand Audoin0Sarah Demortiere1Penelope Tilsley2Ruben Attia3Ruben Fitoussi4Kevin Mairot5Jan-Patrick Stellman6Thierry David7Natacha Stolowy8Neurology, Hospital Timone, Marseille, FranceNeurology, Hospital Timone, Marseille, FranceNeuroimaging service, CRMBM, Marseille, FranceOphthalmology, Hospital Timone, Marseille, FranceOphthalmology, Hospital Timone, Marseille, FranceOphthalmology, Hospital Timone, Marseille, FranceNeuroimaging service, CRMBM, Marseille, FranceOphthalmology, Hospital Timone, Marseille, FranceOphthalmology, Hospital Timone, Marseille, FranceBackground The aim of this study was to assess the risk factors for atrophic progression of patients with papilloedema secondary to intracranial hypertension, using optical coherence tomography parameters.Methods A retrospective study was conducted at Marseille University Hospitals’ Ophthalmology departments between December 2015 and December 2021. All patients with papilloedema resulting from elevated intracranial hypertension at the initial presentation were included. Ophthalmological evaluations included analysing retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) and total peripapillary retinal thickness (RT).Results The study included 222 eyes from 113 patients. The main aetiologies of intracranial hypertension were idiopathic intracranial hypertension (49/113), intracranial tumours (33/113) and cerebral venous thrombosis (15/113). The initial RNFL and RT showed significant correlations with optic atrophy. The mean RNFL was 199.63 µm in the ‘no atrophy’ group and 365.28 µm in the ‘atrophy’ group (p<0.001). Similarly, the mean RT was 483.72 µm in the ‘non-atrophy’ group and 796.69 µm in the ‘atrophy’ group (p<0.001). The presence of peripapillary haemorrhages showed a strong correlated with optic atrophy with an OR=19.12 (p<0.001). Impaired initial visual acuity was also associated with final optic atrophy with an OR=7.76 (p=0.020). Furthermore, impaired initial GCL was a major predictor of optic atrophy (OR=18.25 (p=0.021)).Conclusion Our study highlights the risk factors for optic atrophy in papilloedema, aiming to facilitate the early detection of patients at a high risk of vision loss and enable more aggressive medical or surgical management.https://bmjophth.bmj.com/content/8/1/e001375.full
spellingShingle Bertrand Audoin
Sarah Demortiere
Penelope Tilsley
Ruben Attia
Ruben Fitoussi
Kevin Mairot
Jan-Patrick Stellman
Thierry David
Natacha Stolowy
Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
BMJ Open Ophthalmology
title Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
title_full Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
title_fullStr Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
title_full_unstemmed Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
title_short Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
title_sort risk factors associated with progression from papilloedema to optic atrophy results from a cohort of 113 patients
url https://bmjophth.bmj.com/content/8/1/e001375.full
work_keys_str_mv AT bertrandaudoin riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT sarahdemortiere riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT penelopetilsley riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT rubenattia riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT rubenfitoussi riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT kevinmairot riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT janpatrickstellman riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT thierrydavid riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients
AT natachastolowy riskfactorsassociatedwithprogressionfrompapilloedematoopticatrophyresultsfromacohortof113patients